$JRSH
Jerash Holdings (US), Inc.

2024 Q1 Form 10-Q Financial Statement

#000121390024011589 Filed on February 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2022 Q4
Revenue $21.57M $27.52M $43.03M
YoY Change -9.25% -36.04% 16.87%
Cost Of Revenue $20.07M $23.06M $37.23M
YoY Change -5.85% -38.07% 24.5%
Gross Profit $1.501M $4.462M $5.797M
YoY Change -38.83% -23.02% -16.12%
Gross Profit Margin 6.95% 16.21% 13.47%
Selling, General & Admin $4.521M $3.843M $4.470M
YoY Change 5.55% -14.03% -2.38%
% of Gross Profit 301.3% 86.12% 77.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $657.9K $657.5K $569.0K
YoY Change -2.79% 15.56% -9.94%
% of Gross Profit 43.84% 14.74% 9.82%
Operating Expenses $4.521M $4.086M $4.470M
YoY Change 5.55% -8.58% -2.38%
Operating Profit -$3.021M $375.8K $1.327M
YoY Change 65.03% -71.67% -43.11%
Interest Expense -$220.4K $235.0K $248.9K
YoY Change -17.68% -5.59% 239.67%
% of Operating Profit 62.53% 18.76%
Other Income/Expense, Net $86.49K $380.7K -$111.5K
YoY Change -52.35% -441.55% 1529.56%
Pretax Income -$3.155M $270.7K $1.215M
YoY Change 64.59% -77.72% -47.73%
Income Tax -$16.36K $38.54K $324.4K
% Of Pretax Income 14.24% 26.69%
Net Earnings -$3.089M $220.7K $890.8K
YoY Change 55.66% -75.22% -46.81%
Net Earnings / Revenue -14.32% 0.8% 2.07%
Basic Earnings Per Share $0.02 $0.07
Diluted Earnings Per Share -$0.25 $0.02 $0.07
COMMON SHARES
Basic Shares Outstanding 12.29M shares 12.29M shares 12.43M shares
Diluted Shares Outstanding 12.29M shares 12.41M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.43M $19.62M $24.63M
YoY Change -30.18% -20.34% -26.71%
Cash & Equivalents $12.43M $19.62M $24.63M
Short-Term Investments $0.00
Other Short-Term Assets $5.832M $5.227M $9.174M
YoY Change 30.16% -43.02% 80.83%
Inventory $27.24M $15.94M $26.66M
Prepaid Expenses
Receivables $5.418M $8.473M $5.546M
Other Receivables $0.00 $152.2K $18.91K
Total Short-Term Assets $50.92M $49.41M $66.03M
YoY Change -11.11% -25.17% -3.43%
LONG-TERM ASSETS
Property, Plant & Equipment $25.00M $24.80M $21.23M
YoY Change 11.82% 16.81% 98.53%
Goodwill $499.3K $499.3K $499.3K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.569M $2.545M $2.212M
YoY Change -1.4% 15.08% -26.15%
Total Long-Term Assets $29.33M $28.38M $25.10M
YoY Change 10.94% 13.06% 76.95%
TOTAL ASSETS
Total Short-Term Assets $50.92M $49.41M $66.03M
Total Long-Term Assets $29.33M $28.38M $25.10M
Total Assets $80.25M $77.79M $91.13M
YoY Change -4.15% -14.64% 10.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.340M $2.402M $5.948M
YoY Change 9.64% -59.63% 105.54%
Accrued Expenses $4.176M $2.898M $2.850M
YoY Change 42.49% 1.69% -27.48%
Deferred Revenue $10.20K
YoY Change -98.9%
Short-Term Debt $0.00 $0.00 $4.406M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.78M $8.937M $18.93M
YoY Change 2.3% -52.79% 77.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.036M $613.9K $1.133M
YoY Change -0.28% -45.81% -39.21%
Total Long-Term Liabilities $1.036M $613.9K $1.133M
YoY Change -0.28% -45.81% -39.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.78M $8.937M $18.93M
Total Long-Term Liabilities $1.036M $613.9K $1.133M
Total Liabilities $15.81M $9.551M $20.06M
YoY Change 2.13% -52.4% 56.26%
SHAREHOLDERS EQUITY
Retained Earnings $41.70M $45.41M
YoY Change -9.68%
Common Stock $12.53K $12.53K $12.53K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.169M $1.169M $771.9K
YoY Change 0.0% 51.45%
Treasury Stock Shares 156.6K shares
Shareholders Equity $64.39M $68.15M $71.07M
YoY Change
Total Liabilities & Shareholders Equity $80.25M $77.79M $91.13M
YoY Change -4.15% -14.64% 10.39%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income -$3.089M $220.7K $890.8K
YoY Change 55.66% -75.22% -46.81%
Depreciation, Depletion And Amortization $657.9K $657.5K $569.0K
YoY Change -2.79% 15.56% -9.94%
Cash From Operating Activities -$5.382M -$313.0K $220.6K
YoY Change -667.32% -241.89% -94.93%
INVESTING ACTIVITIES
Capital Expenditures $416.9K $184.3K $208.0K
YoY Change -105.82% -11.39% -129.26%
Acquisitions
YoY Change
Other Investing Activities -$462.1K -$619.7K -$713.5K
YoY Change -95.17% -13.15% -44.11%
Cash From Investing Activities -$879.0K -$804.0K -$921.5K
YoY Change -63.42% -12.75% -53.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -614.7K -612.9K 2.454M
YoY Change -88.66% -124.97% -56.59%
NET CHANGE
Cash From Operating Activities -5.382M -313.0K 220.6K
Cash From Investing Activities -879.0K -804.0K -921.5K
Cash From Financing Activities -614.7K -612.9K 2.454M
Net Change In Cash -6.876M -1.730M 1.753M
YoY Change -0.01% -198.66% -78.13%
FREE CASH FLOW
Cash From Operating Activities -$5.382M -$313.0K $220.6K
Capital Expenditures $416.9K $184.3K $208.0K
Free Cash Flow -$5.799M -$497.4K $12.62K
YoY Change -171.48% -4041.05% -99.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38474
dei Entity Registrant Name
EntityRegistrantName
Jerash Holdings (US), Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
277 Fairfield Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 338
dei Entity Address City Or Town
EntityAddressCityOrTown
Fairfield
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07004
dei City Area Code
CityAreaCode
(201)
dei Local Phone Number
LocalPhoneNumber
285-7973
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
JRSH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12294840 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19617630 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17801614 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8472674 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2240537 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
152188 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
87573 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
15937648 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
32656833 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2582886 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2964578 usd
CY2023Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
2644108 usd
CY2023Q1 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
1533091 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
57284226 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1608784 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1609989 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
782697 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
841628 usd
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
153873 usd
CY2023Q1 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
153873 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24796611 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22355574 usd
CY2023Q4 us-gaap Goodwill
Goodwill
499282 usd
CY2023Q1 us-gaap Goodwill
Goodwill
499282 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
541612 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
974761 usd
CY2023Q4 us-gaap Assets
Assets
77789993 usd
CY2023Q1 us-gaap Assets
Assets
83719333 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2401586 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5782570 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2898142 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2930533 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1736484 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2846201 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
1619636 usd
CY2023Q1 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
1477243 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
905 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
928393 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
280363 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
481502 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8937116 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14446442 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
196456 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
287247 usd
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
417450 usd
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
751410 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9551022 usd
CY2023Q1 us-gaap Liabilities
Liabilities
15485099 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12534318 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12534318 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12294840 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12294840 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12534 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
12534 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23658744 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22931046 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
239478 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
239478 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1169046 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1169046 usd
CY2023Q4 us-gaap Other Additional Capital
OtherAdditionalCapital
410847 usd
CY2023Q1 us-gaap Other Additional Capital
OtherAdditionalCapital
410847 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
45410712 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
46172082 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-178558 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-123229 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
68145233 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
68234234 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
93738 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
68238971 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
68234234 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77789993 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83719333 usd
CY2023Q4 us-gaap Revenues
Revenues
27520121 usd
CY2022Q4 us-gaap Revenues
Revenues
43027047 usd
us-gaap Revenues
Revenues
95612886 usd
us-gaap Revenues
Revenues
114289303 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23057845 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
37230421 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
80211039 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94952523 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
4462276 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
5796626 usd
us-gaap Gross Profit
GrossProfit
15401847 usd
us-gaap Gross Profit
GrossProfit
19336780 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3843029 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4469967 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12318535 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12796749 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
243448 usd
us-gaap Share Based Compensation
ShareBasedCompensation
727698 usd
us-gaap Share Based Compensation
ShareBasedCompensation
294822 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
4086477 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
4469967 usd
us-gaap Operating Expenses
OperatingExpenses
13046233 usd
us-gaap Operating Expenses
OperatingExpenses
13091571 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
375799 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1326659 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2355614 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
6245209 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
234971 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
248894 usd
us-gaap Interest Expense
InterestExpense
983156 usd
us-gaap Interest Expense
InterestExpense
500331 usd
CY2023Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
129877 usd
CY2022Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
137432 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
412627 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
255481 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-105094 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-111462 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-570529 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-244850 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
270705 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1215197 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1785085 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6000359 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38535 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
324379 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
688856 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1596407 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
232170 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
890818 usd
us-gaap Profit Loss
ProfitLoss
1096229 usd
us-gaap Profit Loss
ProfitLoss
4403952 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11457 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
13373 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
220713 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
890818 usd
us-gaap Net Income Loss
NetIncomeLoss
1082856 usd
us-gaap Net Income Loss
NetIncomeLoss
4403952 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
232170 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
890818 usd
us-gaap Profit Loss
ProfitLoss
1096229 usd
us-gaap Profit Loss
ProfitLoss
4403952 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
99171 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
37804 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-55329 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-296066 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
331341 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
928622 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1040900 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4107886 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
11457 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
13373 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
319884 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
928622 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1027527 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4107886 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12294840 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12412922 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12294840 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12414546 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12294840 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12412922 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12294840 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12467315 shares
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
69304258 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
294822 usd
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
-771894 usd
us-gaap Profit Loss
ProfitLoss
4403952 usd
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
1865241 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-296066 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
71069831 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
68234234 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
727698 usd
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
31365 usd
jrsh Noncontrolling Interest Increases From Business Combination
NoncontrollingInterestIncreasesFromBusinessCombination
49000 usd
us-gaap Profit Loss
ProfitLoss
1096229 usd
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
1844226 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-55329 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
68238971 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
70987199 usd
CY2022Q4 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
-224181 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
890818 usd
CY2022Q4 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
621809 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
37804 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
71069831 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
68229924 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
243448 usd
CY2023Q4 jrsh Noncontrolling Interest Increases From Business Combination
NoncontrollingInterestIncreasesFromBusinessCombination
49000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
232170 usd
CY2023Q4 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
614742 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
99171 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
68238971 usd
us-gaap Profit Loss
ProfitLoss
1096229 usd
us-gaap Profit Loss
ProfitLoss
4403952 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1881853 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1753941 usd
us-gaap Share Based Compensation
ShareBasedCompensation
727698 usd
us-gaap Share Based Compensation
ShareBasedCompensation
294822 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-187762 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
601727 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
784699 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6044375 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5503123 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
64614 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16719185 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1591135 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-350324 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-424867 usd
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
1111017 usd
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
4725296 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3380984 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1108112 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-32390 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-266092 usd
jrsh Increase Decrease In Other Payables
IncreaseDecreaseInOtherPayables
142393 usd
jrsh Increase Decrease In Other Payables
IncreaseDecreaseInOtherPayables
-883219 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-927488 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
296985 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-460508 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-661274 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1443317 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
232632 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7866954 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9858387 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
824305 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
587613 usd
jrsh Payments For Construction Of Properties
PaymentsForConstructionOfProperties
3158501 usd
jrsh Payments For Construction Of Properties
PaymentsForConstructionOfProperties
3414172 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5100000 usd
CY2023Q4 jrsh Inventory Based Orders Received Percentage
InventoryBasedOrdersReceivedPercentage
0.932 pure
CY2023Q1 jrsh Inventory Based Orders Received Percentage
InventoryBasedOrdersReceivedPercentage
0.934 pure
us-gaap Payments For Proceeds From Previous Acquisition
PaymentsForProceedsFromPreviousAcquisition
2200000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
281153 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
70549 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4263959 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11372334 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1844226 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1865241 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
31365 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
771894 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
4937633 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1756360 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
300166 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
4937633 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
6162743 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1812861 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1469082 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24677 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-296261 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1814811 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-341126 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19411603 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26583488 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21226414 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26242362 usd
CY2023Q4 jrsh Cash And Restricted Cash End Of Year
CashAndRestrictedCashEndOfYear
21226414 usd
CY2022Q4 jrsh Cash And Restricted Cash End Of Year
CashAndRestrictedCashEndOfYear
26242362 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1608784 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1615353 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19617630 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24627009 usd
us-gaap Interest Paid Net
InterestPaidNet
983156 usd
us-gaap Interest Paid Net
InterestPaidNet
500331 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
2163732 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1354754 usd
jrsh Equipment Obtained By Utilizing Longterm Deposit
EquipmentObtainedByUtilizingLongtermDeposit
355160 usd
jrsh Equipment Obtained By Utilizing Longterm Deposit
EquipmentObtainedByUtilizingLongtermDeposit
236735 usd
jrsh Acquisition Of Kawkab Venus By Utilizing Longterm Deposit
AcquisitionOfKawkabVenusByUtilizingLongtermDeposit
500000 usd
jrsh Right Of Use Assets Obtained In Exchange For Operating Lease Obligations
RightOfUseAssetsObtainedInExchangeForOperatingLeaseObligations
177068 usd
jrsh Right Of Use Assets Obtained In Exchange For Operating Lease Obligations
RightOfUseAssetsObtainedInExchangeForOperatingLeaseObligations
190654 usd
CY2023Q1 us-gaap Capital
Capital
500000 hkd
CY2023Q1 us-gaap Capital
Capital
64000 usd
CY2023Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
29900000 usd
CY2023Q4 us-gaap Capital
Capital
100000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
499282 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
93738 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the unaudited condensed consolidated financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates.</p>
CY2023Q1 us-gaap Goodwill
Goodwill
499282 usd
CY2023Q4 jrsh Inventories Held On Hand Unfulfilled Sales Orders Percentage
InventoriesHeldOnHandUnfulfilledSalesOrdersPercentage
0.068 pure
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
905 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
928393 usd
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
905 usd
CY2023Q4 us-gaap Other Expenses
OtherExpenses
380696 usd
CY2022Q4 us-gaap Other Expenses
OtherExpenses
573249 usd
us-gaap Other Expenses
OtherExpenses
1479715 usd
us-gaap Other Expenses
OtherExpenses
1449052 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01 pure
us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.50 pure
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentrations and Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Credit risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of December 31, 2023 and March 31, 2023, respectively, $5,605,645 and $7,264,247 of the Company’s cash were on deposit at financial institutions in Jordan, where there currently is no rule or regulation requiring such financial institutions to maintain insurance to cover bank deposits in the event of bank failure. As of December 31, 2023 and March 31, 2023, $297,868 and $172,939 of the Company’s cash were on deposit at financial institutions in China, respectively. Cash maintained in banks within China of less than CNY 0.5 million (equivalent to $70,723) per bank is covered by “deposit insurance regulation” promulgated by the State Council of the People’s Republic of China. As of December 31, 2023 and March 31, 2023, $14,609,576 and $11,700,512 of the Company’s cash were on deposit at financial institutions in Hong Kong, respectively, which are insured by the Hong Kong Deposit Protection Board subject to certain limitations. While management believes that these financial institutions are of high credit quality, it also continually monitors their creditworthiness. As of December 31, 2023 and March 31, 2023, $530,078 and $171,496 of the Company’s cash were on deposit in the United States, respectively, and are insured by the Federal Deposit Insurance Corporation up to $250,000.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable are typically unsecured and derived from revenue earned from customers, and therefore are exposed to credit risk. The risk is mitigated by the Company’s assessment of its customers’ creditworthiness and its ongoing monitoring of outstanding balances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advance to suppliers are typically unsecured and derived from deposit placed to suppliers to secure the quantity of raw materials and garments for production. The Company is exposed to credit risk in that the supplier will not deliver the required quantity to the Company. The risk is mitigated by the Company’s assessment of its production requirement and its suppliers’ creditworthiness and its ongoing monitoring of outstanding balances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Customer and vendor concentration risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s sales are made primarily in the United States. Its operating results could be adversely affected by U.S. government policies on importing business, foreign exchange rate fluctuations, and changes in local market conditions. The Company has a concentration of its revenue and purchases with specific customers and suppliers. For the three and nine months ended December 31, 2023, two customers accounted for 63% and 13%, and 68% and 13% of the Company’s total revenue, respectively. For the three months ended December 31, 2022, four end-customers accounted for 43%, 20%, 19%, and 10% of the Company’s total revenue, respectively. For the nine months ended December 31, 2022, two end-customers accounted for 57% and 18% of the Company’s total revenue, respectively. As of December 31, 2023, three customers accounted for 40%, 22%, and 13% of the Company’s total accounts receivable balance, respectively. As of March 31, 2023, four customers accounted for 50%, 13%, 10%, and 10% of the Company’s total accounts receivable balance, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended December 31, 2023, the Company purchased approximately 17% and 14% of its garments and raw materials from two major suppliers. For the nine months ended December 31, 2023, the Company purchased approximately 13% of its garments from one major supplier. For the three months ended December 31, 2022, the Company purchased approximately 28% of its garments from one major supplier. For the nine months ended December 31, 2022, the Company purchased approximately 13% and 10% of its garments and raw materials from two major suppliers, respectively. As of December 31, 2023, accounts payable to the Company’s one major supplier accounted for 26% of the total accounts payable balance. As of March 31, 2023, accounts payable to the Company’s one major supplier accounted for 36% of the total accounts payable balance.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no effect on net income or cash flow as previously reported. </p>
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
8506495 usd
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2462120 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
33821 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
221583 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
8472674 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
2240537 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
3356836 usd
CY2023Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
15240198 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2335840 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2932519 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10244972 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
14484116 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
15937648 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
32656833 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
153924 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5395 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
571355 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
29744 usd
CY2023Q1 jrsh Inventories Held On Hand Unfulfilled Sales Orders Percentage
InventoriesHeldOnHandUnfulfilledSalesOrdersPercentage
0.066 pure
CY2023Q4 jrsh Advances On Inventory Purchases Gross
AdvancesOnInventoryPurchasesGross
2644108 usd
CY2023Q1 jrsh Advances On Inventory Purchases Gross
AdvancesOnInventoryPurchasesGross
1533091 usd
CY2023Q4 jrsh Advance To Suppliers Net
AdvanceToSuppliersNet
2644108 usd
CY2023Q1 jrsh Advance To Suppliers Net
AdvanceToSuppliersNet
1533091 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
541612 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
974761 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
280363 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
481502 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
196456 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
287247 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
476819 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
768749 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.061 pure
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.061 pure
CY2023Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
599622 usd
CY2022Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
599906 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
1904329 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
1866619 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
123353 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
288683 usd
CY2023Q4 jrsh Lessee Operating Lease Liability Prepayments
LesseeOperatingLeaseLiabilityPrepayments
-64792 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
476819 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31659210 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29315676 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15970930 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14142469 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24796611 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22355574 usd
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
874000 jod
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1233000 usd
CY2022Q2 us-gaap Area Of Land
AreaOfLand
4516 sqm
CY2022Q2 us-gaap Area Of Land
AreaOfLand
48608 sqft
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
6300000 jod
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
8900000 usd
CY2023Q4 us-gaap Property Plant And Equipment Salvage Value
PropertyPlantAndEquipmentSalvageValue
161000 jod
CY2023Q4 us-gaap Property Plant And Equipment Salvage Value
PropertyPlantAndEquipmentSalvageValue
227000 usd
CY2022Q3 us-gaap Contributions In Aid Of Construction
ContributionsInAidOfConstruction
39600000 hkd
CY2022Q3 us-gaap Contributions In Aid Of Construction
ContributionsInAidOfConstruction
5100000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
657531 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
569001 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1881853 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1753941 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12294840 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12294840 shares
CY2023Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
239478 shares
us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
1169046 usd
jrsh Statutory Reserve Percentage
StatutoryReservePercentage
0.10 pure
jrsh Entitys Share Capital Percentage
EntitysShareCapitalPercentage
1 pure
jrsh Aftertax Net Profits Percentage
AftertaxNetProfitsPercentage
0.10 pure
jrsh Percentage Of Registered Capital Reserves
PercentageOfRegisteredCapitalReserves
0.50 pure
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
614742 usd
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
614742 usd
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
614742 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.05
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
618886 usd
CY2022Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
621809 usd
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
626716 usd
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
616716 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
137210 shares
CY2018Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1484250 shares
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1029150 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
986500 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
150000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
200000 shares
CY2022Q2 jrsh Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Option
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOption
200000 usd
CY2023Q1 us-gaap Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation
EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation
1937695 usd
us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
1087577 usd
jrsh Sharebased Compensation Arrangement By Sharebased Payment Award Rs Us Remained
SharebasedCompensationArrangementBySharebasedPaymentAwardRSUsRemained
405100 shares
CY2023Q4 us-gaap Restricted Stock Expense
RestrictedStockExpense
243448 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
727698 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
294822 usd
CY2023Q4 us-gaap Payments For Fees
PaymentsForFees
222219 usd
CY2022Q4 us-gaap Payments For Fees
PaymentsForFees
199448 usd
us-gaap Payments For Fees
PaymentsForFees
919165 usd
us-gaap Payments For Fees
PaymentsForFees
450885 usd
CY2023Q2 jrsh Document Received
DocumentReceived
10000000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
555100 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1193700 shares
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
220713 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
890818 usd
us-gaap Net Income Loss
NetIncomeLoss
1082856 usd
us-gaap Net Income Loss
NetIncomeLoss
4403952 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12294840 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12412922 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12294840 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12414546 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
52769 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12294840 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12412922 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12294840 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12467315 shares
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2023Q4 jrsh Revenue Percentage
RevenuePercentage
0.888 pure
CY2022Q4 jrsh Revenue Percentage
RevenuePercentage
0.941 pure
jrsh Revenue Percentage
RevenuePercentage
0.911 pure
jrsh Revenue Percentage
RevenuePercentage
0.938 pure
CY2023Q4 us-gaap Revenues
Revenues
27520121 usd
CY2022Q4 us-gaap Revenues
Revenues
43027047 usd
us-gaap Revenues
Revenues
95612886 usd
us-gaap Revenues
Revenues
114289303 usd
CY2019Q3 us-gaap Capital Units
CapitalUnits
3000000 hkd
CY2019Q3 us-gaap Capital Units
CapitalUnits
385000 usd
CY2020Q4 us-gaap Capital Units
CapitalUnits
15000000 hkd
CY2020Q4 us-gaap Capital Units
CapitalUnits
1900000 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
15000000 hkd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
1900000 usd
us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
10000000 hkd
us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
1300000 usd
us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
1 pure
jrsh Effective Ncome Tax Rate Reconsilation Tax Exemption Period
EffectiveNcomeTaxRateReconsilationTaxExemptionPeriod
P10Y
jrsh Effective Ncome Tax Rate Reconsilation Tax Exemption Extension Period
EffectiveNcomeTaxRateReconsilationTaxExemptionExtensionPeriod
P5Y
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01 pure
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.142 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.386 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q4 us-gaap Assets Current
AssetsCurrent
49407134 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Payments For Proceeds From Previous Acquisition
PaymentsForProceedsFromPreviousAcquisition
usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
jrsh Acquisition Of Kawkab Venus By Utilizing Longterm Deposit
AcquisitionOfKawkabVenusByUtilizingLongtermDeposit
usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
usd
CY2023Q4 jrsh Allowances For Credit Losses
AllowancesForCreditLosses
usd
CY2023Q1 jrsh Allowances For Credit Losses
AllowancesForCreditLosses
usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P2Y
CY2022Q4 us-gaap Restricted Stock Expense
RestrictedStockExpense
usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
usd
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
usd
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001696558

Files In Submission

Name View Source Status
0001213900-24-011589-index-headers.html Edgar Link pending
0001213900-24-011589-index.html Edgar Link pending
0001213900-24-011589.txt Edgar Link pending
0001213900-24-011589-xbrl.zip Edgar Link pending
ex10-2_001.jpg Edgar Link pending
ex10-2_002.jpg Edgar Link pending
ex10-2_003.jpg Edgar Link pending
ex10-2_004.jpg Edgar Link pending
ex10-2_005.jpg Edgar Link pending
ex10-2_006.jpg Edgar Link pending
ex10-2_007.jpg Edgar Link pending
ex10-2_008.jpg Edgar Link pending
ex10-2_009.jpg Edgar Link pending
ex10-2_010.jpg Edgar Link pending
ex10-2_011.jpg Edgar Link pending
ex10-2_012.jpg Edgar Link pending
ex10-2_013.jpg Edgar Link pending
ex10-2_014.jpg Edgar Link pending
ex10-2_015.jpg Edgar Link pending
f10q1223ex10-2_jerashhold.htm Edgar Link pending
f10q1223ex31-1_jerashhold.htm Edgar Link pending
f10q1223ex31-2_jerashhold.htm Edgar Link pending
f10q1223ex32-1_jerashhold.htm Edgar Link pending
f10q1223ex32-2_jerashhold.htm Edgar Link pending
f10q1223_jerashhold.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jrsh-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
jrsh-20231231_def.xml Edgar Link unprocessable
jrsh-20231231_pre.xml Edgar Link unprocessable
f10q1223_jerashhold_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
jrsh-20231231_cal.xml Edgar Link unprocessable
jrsh-20231231_lab.xml Edgar Link unprocessable